According to a recent LinkedIn post from Aignostics, the company is promoting a Research Access Program that offers academic researchers free use of its Atlas H&E-TME spatial tumor microenvironment analysis tool. The post indicates that participants can have their own H&E slide images fully processed, with spatial readouts available at the cell, tissue, and neighborhood levels, along with polygon overlays in Aignostics’ pathology viewer.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The LinkedIn post also notes that the program includes dedicated support from the Aignostics team and specifies that there is no cost to apply or participate. For investors, this initiative suggests a strategy to drive broader academic engagement, generate real-world validation data, and increase familiarity with the Atlas H&E-TME platform, which could support future commercialization efforts and strengthen Aignostics’ positioning in digital pathology and spatial biology analytics.